Phenotypic heterogeneity in small cell lung cancer models in vitro and in vivo
Small cell lung cancer (SCLC) accounts for around 15% of new cases and 25% of deaths from lung cancer, making it the most aggressive subtype. This is due to the fact that tumours quickly develop resistance to therapy and metastasise early to the brain, liver and bone marrow. SCLC is normally charact...
Main Author: | Meredith, Suzanne |
---|---|
Other Authors: | White, Anne; Dive, Caroline |
Published: |
University of Manchester
2013
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.574381 |
Similar Items
-
Effects of lung tumour cells on the phenotype and function of human astrocytes and endolithial cells
by: Maskell, Lesley
Published: (2008) -
Pre-clinical evaluation of Bcl-2 inhibitor ABT-737 in small cell lung cancer
by: Micha, Dimitra
Published: (2009) -
Analysis of the structure and function of the erythropoietin receptor in non-small cell lung carcinoma
by: Dunlop, E. A.
Published: (2006) -
Cancer in older people : studies in lung cancer
by: Turner, Nicola Jane
Published: (2003) -
Targeting SRC family kinases in lung cancer
by: Rupniewska, Ewa
Published: (2012)